Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review

BACKGROUND: Evidence remains contradictory regarding second-line therapy in patients with Kawasaki disease (KD) refractory to initial intravenous immunoglobulin (IVIg). The objective of this study aims to evaluate the efficacy and safety of three treatments [i.e. a second IVIg infusion, methylpredni...

Descripción completa

Detalles Bibliográficos
Autores principales: Crayne, Courtney B., Mitchell, Chace, Beukelman, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882052/
https://www.ncbi.nlm.nih.gov/pubmed/31775898
http://dx.doi.org/10.1186/s12969-019-0380-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882052/
https://www.ncbi.nlm.nih.gov/pubmed/31775898
http://dx.doi.org/10.1186/s12969-019-0380-z

Ejemplares similares